Whilst I see the tie in and ICU is a company with great prospects and a bright future, the benefits at this point lie squarely in the ICU camp, not LT holders of MLA.[/QUOTE]
Impart, as a long term holder as well I agree with you that the benefits seem to be going ICU way.
Unfortunately independent experts report won't show their synergy benefits, it will only look at MLA in isolation.
At this stage I'm inclined to say no anywhere below 10cts.
Pitt
DYOR, IMHO etc
MLA Price at posting:
8.3¢ Sentiment: Buy Disclosure: Held
